Article

Functional amyloids as natural storage of peptide hormones in pituitary secretory granules

Laboratory of Physical Chemistry, Eidgenössische Technische Hochschule (ETH) Zürich, Wolfgang-Paulistrasse 10, CH-8093 Zürich, Switzerland.
Science (Impact Factor: 31.48). 07/2009; 325(5938):328-32. DOI: 10.1126/science.1173155
Source: PubMed

ABSTRACT Amyloids are highly organized cross-beta-sheet-rich protein or peptide aggregates that are associated with pathological conditions including Alzheimer's disease and type II diabetes. However, amyloids may also have a normal biological function, as demonstrated by fungal prions, which are involved in prion replication, and the amyloid protein Pmel17, which is involved in mammalian skin pigmentation. We found that peptide and protein hormones in secretory granules of the endocrine system are stored in an amyloid-like cross-beta-sheet-rich conformation. Thus, functional amyloids in the pituitary and other organs can contribute to normal cell and tissue physiology.

Download full-text

Full-text

Available from: Michael R Sawaya, Jun 23, 2014
0 Followers
 · 
161 Views
  • Source
    • "An active, amyloidogenic and dominantly selfperpetuating form of cytoplasmic polyadenylation element binding protein (CPEB) might play a role in persistent synaptic facilitation in sensory neurons of the sea slug, Aplysia (Si et al., 2010). Furthermore , many peptide and protein hormones may be stored in secretory granules of mammalian endocrine cells in an amyloidlike state (Maji et al., 2009). Given its involvement in the pathology of the prion diseases it is unlikely that PrP Sc has a cellular function, but single nucleotide polymorphisms in the human gene for PrP have been associated with differences in long term memory in healthy young adults (Papassotiropoulos et al., 2005), and aggregated, non-infectious states have been shown for PrP by numerous investigators (Baskakov and Breydo, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The cellular prion protein (PrP(C)) is an ubiquitously expressed glycoprotein that is most abundant in the central nervous system. It is thought to play a role in many cellular processes, including neuroprotection, but may also contribute to Alzheimer's disease and some cancers. However, it is best known for its central role in the prion diseases, such as Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy (BSE), and scrapie. These protein misfolding diseases can be sporadic, acquired, or genetic and are caused by refolding of endogenous PrP(C) into a beta sheet-rich, pathogenic form, PrP(Sc). Once prions are present in the central nervous system, they increase and spread during a long incubation period that is followed by a relatively short clinical disease phase, ending in death. PrP molecules can be broadly categorized as either 'good' (cellular) PrP(C) or 'bad' (scrapie prion-type) PrP(Sc), but both populations are heterogeneous and different forms of PrP(C) may influence various cellular activities. Both PrP(C) and PrP(Sc) are localized predominantly at the cell surface, with the C-terminus attached to the plasma membrane via a glycosyl-phosphatidylinositol (GPI) anchor and both can exist in cleaved forms. PrP(C) also has cytosolic and transmembrane forms, and PrP(Sc) is known to exist in a variety of conformations and aggregation states. Here, we discuss the roles of different PrP isoforms in sickness and in health, and show the subcellular distributions of several forms of PrP that are particularly relevant for PrP(C) to PrP(Sc) conversion and prion-induced pathology in the hippocampus. Copyright © 2015. Published by Elsevier B.V.
    Virus Research 02/2015; 584. DOI:10.1016/j.virusres.2015.02.004 · 2.83 Impact Factor
  • Source
    • "A recent report showed that peptide hormones of the pituitary gland are stored intracellularly as amyloid aggregates within the secretion granules. The amyloid cross-β structure provides a very stable and highly compacted state from which controlled release of functional monomeric hormone can take place upon signaling (Maji et al., 2009). A somewhat similar situation occurs with bacterial IBs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The formation of inclusion bodies (IBs) constitute a frequent event during the production of heterologous proteins in bacterial hosts. Although the mechanisms leading to their formation are not completely understood, empirical data have been exploited trying to predict the aggregation propensity of specific proteins while a great number of strategies have been developed to avoid the generation of IBs. However, in many cases, the formation of such aggregates can be considered an advantage for basic research as for protein production. In this review, we focus on this positive side of IBs formation in bacteria. We present a compilation on recent advances on the understanding of IBs formation and their utilization as a model to understand protein aggregation and to explore strategies to control this process. We include recent information about their composition and structure, their use as an attractive approach to produce low cost proteins and other promising applications in Biomedicine.
    Frontiers in Microbiology 02/2014; 5:56. DOI:10.3389/fmicb.2014.00056 · 3.94 Impact Factor
  • Source
    • "The amyloid plaque formation could be a dynamic process between protein monomers, oligomers, and fibrils . Amyloid fibrils can be an integral part of normal cellular physiology and serve as storage reservoirs for peptide hormones within secretory granules (Maji et al., 2009). Although Aβ or amylin insoluble fibrils may play some physiological/pathophysiological roles, it is the soluble oligomeric intermediates that are believed to represent the primary toxic species of amyloids (Hardy and Selkoe, 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Amylin (islet amyloid polypeptide) and amyloid-beta (Aβ) protein, which are deposited within pancreatic islets of diabetics and brains of Alzheimer's patients respectively, share many biophysical and physiological properties. Emerging evidence indicates that the amylin receptor is a putative target receptor for the actions of human amylin and Aβ in the brain. The amylin receptor consists of the calcitonin receptor dimerized with a receptor activity-modifying protein and is widely distributed within central nervous system. Both amylin and Aβ directly activate this G protein-coupled receptor and trigger multiple common intracellular signal transduction pathways that can culminate in apoptotic cell death. Moreover, amylin receptor antagonists can block both the biological and neurotoxic effects of human amylin and Aβ. Amylin receptors thus appear to be involved in the pathophysiology of Alzheimer's disease and diabetes, and could serve as a molecular link between the two conditions that are associated epidemiologically.
    Frontiers in Aging Neuroscience 08/2013; 5:42. DOI:10.3389/fnagi.2013.00042 · 2.84 Impact Factor